A9502 HCPCS code: Technetium tc-99m tetrofosmin, diagnostic, per study dose
A9502 is the HCPCS Level II code for technetium tc-99m tetrofosmin, diagnostic, per study dose. In 2024 Medicare paid an average of $144.87 per service for A9502 across 387,198 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 7% from 2022 to 2024 (414,506 to 387,198 services). In 2024, about 4,121 clinicians billed Medicare for A9502 for 231,915 beneficiaries; Florida, California, New York accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 1998-01-01 |
| Last action effective | 2009-01-01 |
Who bills A9502 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,121 |
| Medicare beneficiaries | 231,915 |
| States with claims | 43 |
| Share of services in top 3 states (Florida, California, New York) | 38% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9502, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 414,506 | 252,160 | $139.93 | $111.47 |
| 2023 | 412,111 | 248,354 | $168.66 | $134.28 |
| 2024 | 387,198 | 231,915 | $182.06 | $144.87 |
States with the most A9502 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 71,628 | $294.04 |
| California | 42,359 | $75.54 |
| New York | 34,475 | $268.87 |
| Georgia | 27,770 | $90.36 |
| Arizona | 27,733 | $75.41 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Clinical: Society Comment |
| practitioner claims | 3 | Clinical: Society Comment |
Medicare policy articles for this code
- A56476: Billing and Coding: Cardiac Radionuclide Imaging (Palmetto GBA (MAC - Part A, MAC - Part B))
- A56494: Billing and Coding: Cardiovascular Nuclear Medicine (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
- A56743: Billing and Coding: Cardiovascular Nuclear Medicine (National Government Services, Inc. (MAC - Part A, MAC - Part B))
Covered diagnoses (687 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| I20.0 | Unstable angina | 3 |
| I20.1 | Angina pectoris with documented spasm | 3 |
| I20.81 | Angina pectoris with coronary microvascular dysfunction | 3 |
| I20.89 | Other forms of angina pectoris | 3 |
| I20.9 | Angina pectoris, unspecified | 3 |
| I21.01 | ST elevation (STEMI) myocardial infarction involving left main coronary artery | 3 |
| I21.02 | ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery | 3 |
| I21.09 | ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall | 3 |
| I21.11 | ST elevation (STEMI) myocardial infarction involving right coronary artery | 3 |
| I21.19 | ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall | 3 |
Showing 10 of 687. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for A9502
- 1998-01-01: A9502 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9502?
A9502 is the HCPCS Level II code for technetium tc-99m tetrofosmin, diagnostic, per study dose. Short descriptor: "Tc99m tetrofosmin".
How much does Medicare pay for A9502?
In 2024, the average Medicare payment was $144.87 per service (average allowed $182.06).
Does Medicare cover A9502?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for A9502?
Medicare policy articles that cite A9502 list 687 covered ICD-10-CM diagnosis codes across 3 articles. The most cited include I20.0 (Unstable angina), I20.1 (Angina pectoris with documented spasm), I20.81 (Angina pectoris with coronary microvascular dysfunction). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of A9502 can be billed per day?
3 on outpatient hospital claims; 3 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
- A9513 — Lutetium lu 177, dotatate, therapeutic, 1 millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9502
- Watch A9502 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9502
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.